Industry: Medical Devices & Consumables
Published Date: 2024-01-11
Pages: 119 Pages
Report ld: 3030816
Request Sample
Customized Report
A medical device used to quickly inject a specific dose of a drug of a certain type (usually a rescue medication). Most rapid injectors have spring retractable needles, a design that makes the injector easier to use, especially when there is no other person to assist or the injector is not medically trained. When using a self-injector, the injection site should be in accordance with the specific requirements of the relevant drug.
The global market for Quick Injector was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Quick Injector was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Quick Injector was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Quick Injector was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Quick Injector include 3M, GE Healthcare Inc., Stryker Corporation, ZOLL Medical Corporation, Smith’s Group Plc. (Smiths Medical), Teleflex Incorporated, Becton, Dickinson and Company, Soma Technology, Inc and 410 Medical, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Quick Injector, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Quick Injector by region & country, by Type, and by Application.
The Quick Injector market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Quick Injector.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Quick Injector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Quick Injector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Quick Injector in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Quick Injector Product Introduction
1.2 Global Quick Injector Market Size Forecast
1.2.1 Global Quick Injector Sales Value (2019-2030)
1.2.2 Global Quick Injector Sales Volume (2019-2030)
1.2.3 Global Quick Injector Sales Price (2019-2030)
1.3 Quick Injector Market Trends & Drivers
1.3.1 Quick Injector Industry Trends
1.3.2 Quick Injector Market Drivers & Opportunity
1.3.3 Quick Injector Market Challenges
1.3.4 Quick Injector Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Quick Injector Players Revenue Ranking (2023)
2.2 Global Quick Injector Revenue by Company (2019-2024)
2.3 Global Quick Injector Players Sales Volume Ranking (2023)
2.4 Global Quick Injector Sales Volume by Company Players (2019-2024)
2.5 Global Quick Injector Average Price by Company (2019-2024)
2.6 Key Manufacturers Quick Injector Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Quick Injector Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Quick Injector
2.9 Quick Injector Market Competitive Analysis
2.9.1 Quick Injector Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Quick Injector Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Quick Injector as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Single Use
3.1.2 Reusable
3.2 Global Quick Injector Sales Value by Type
3.2.1 Global Quick Injector Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Quick Injector Sales Value, by Type (2019-2030)
3.2.3 Global Quick Injector Sales Value, by Type (%) (2019-2030)
3.3 Global Quick Injector Sales Volume by Type
3.3.1 Global Quick Injector Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Quick Injector Sales Volume, by Type (2019-2030)
3.3.3 Global Quick Injector Sales Volume, by Type (%) (2019-2030)
3.4 Global Quick Injector Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Speciality Clinic
4.2 Global Quick Injector Sales Value by Application
4.2.1 Global Quick Injector Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Quick Injector Sales Value, by Application (2019-2030)
4.2.3 Global Quick Injector Sales Value, by Application (%) (2019-2030)
4.3 Global Quick Injector Sales Volume by Application
4.3.1 Global Quick Injector Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Quick Injector Sales Volume, by Application (2019-2030)
4.3.3 Global Quick Injector Sales Volume, by Application (%) (2019-2030)
4.4 Global Quick Injector Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Quick Injector Sales Value by Region
5.1.1 Global Quick Injector Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Quick Injector Sales Value by Region (2019-2024)
5.1.3 Global Quick Injector Sales Value by Region (2025-2030)
5.1.4 Global Quick Injector Sales Value by Region (%), (2019-2030)
5.2 Global Quick Injector Sales Volume by Region
5.2.1 Global Quick Injector Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Quick Injector Sales Volume by Region (2019-2024)
5.2.3 Global Quick Injector Sales Volume by Region (2025-2030)
5.2.4 Global Quick Injector Sales Volume by Region (%), (2019-2030)
5.3 Global Quick Injector Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Quick Injector Sales Value, 2019-2030
5.4.2 North America Quick Injector Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Quick Injector Sales Value, 2019-2030
5.5.2 Europe Quick Injector Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Quick Injector Sales Value, 2019-2030
5.6.2 Asia Pacific Quick Injector Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Quick Injector Sales Value, 2019-2030
5.7.2 South America Quick Injector Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Quick Injector Sales Value, 2019-2030
5.8.2 Middle East & Africa Quick Injector Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Quick Injector Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Quick Injector Sales Value
6.2.1 Key Countries/Regions Quick Injector Sales Value, 2019-2030
6.2.2 Key Countries/Regions Quick Injector Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Quick Injector Sales Value, 2019-2030
6.3.2 United States Quick Injector Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Quick Injector Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Quick Injector Sales Value, 2019-2030
6.4.2 Europe Quick Injector Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Quick Injector Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Quick Injector Sales Value, 2019-2030
6.5.2 China Quick Injector Sales Value by Type (%), 2023 VS 2030
6.5.3 China Quick Injector Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Quick Injector Sales Value, 2019-2030
6.6.2 Japan Quick Injector Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Quick Injector Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Quick Injector Sales Value, 2019-2030
6.7.2 South Korea Quick Injector Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Quick Injector Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Quick Injector Sales Value, 2019-2030
6.8.2 Southeast Asia Quick Injector Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Quick Injector Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Quick Injector Sales Value, 2019-2030
6.9.2 India Quick Injector Sales Value by Type (%), 2023 VS 2030
6.9.3 India Quick Injector Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 3M
7.1.1 3M Company Information
7.1.2 3M Introduction and Business Overview
7.1.3 3M Quick Injector Sales, Revenue and Gross Margin (2019-2024)
7.1.4 3M Quick Injector Product Offerings
7.1.5 3M Recent Development
7.2 GE Healthcare Inc.
7.2.1 GE Healthcare Inc. Company Information
7.2.2 GE Healthcare Inc. Introduction and Business Overview
7.2.3 GE Healthcare Inc. Quick Injector Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GE Healthcare Inc. Quick Injector Product Offerings
7.2.5 GE Healthcare Inc. Recent Development
7.3 Stryker Corporation
7.3.1 Stryker Corporation Company Information
7.3.2 Stryker Corporation Introduction and Business Overview
7.3.3 Stryker Corporation Quick Injector Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Stryker Corporation Quick Injector Product Offerings
7.3.5 Stryker Corporation Recent Development
7.4 ZOLL Medical Corporation
7.4.1 ZOLL Medical Corporation Company Information
7.4.2 ZOLL Medical Corporation Introduction and Business Overview
7.4.3 ZOLL Medical Corporation Quick Injector Sales, Revenue and Gross Margin (2019-2024)
7.4.4 ZOLL Medical Corporation Quick Injector Product Offerings
7.4.5 ZOLL Medical Corporation Recent Development
7.5 Smith’s Group Plc. (Smiths Medical)
7.5.1 Smith’s Group Plc. (Smiths Medical) Company Information
7.5.2 Smith’s Group Plc. (Smiths Medical) Introduction and Business Overview
7.5.3 Smith’s Group Plc. (Smiths Medical) Quick Injector Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Smith’s Group Plc. (Smiths Medical) Quick Injector Product Offerings
7.5.5 Smith’s Group Plc. (Smiths Medical) Recent Development
7.6 Teleflex Incorporated
7.6.1 Teleflex Incorporated Company Information
7.6.2 Teleflex Incorporated Introduction and Business Overview
7.6.3 Teleflex Incorporated Quick Injector Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Teleflex Incorporated Quick Injector Product Offerings
7.6.5 Teleflex Incorporated Recent Development
7.7 Becton, Dickinson and Company
7.7.1 Becton, Dickinson and Company Company Information
7.7.2 Becton, Dickinson and Company Introduction and Business Overview
7.7.3 Becton, Dickinson and Company Quick Injector Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Becton, Dickinson and Company Quick Injector Product Offerings
7.7.5 Becton, Dickinson and Company Recent Development
7.8 Soma Technology, Inc
7.8.1 Soma Technology, Inc Company Information
7.8.2 Soma Technology, Inc Introduction and Business Overview
7.8.3 Soma Technology, Inc Quick Injector Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Soma Technology, Inc Quick Injector Product Offerings
7.8.5 Soma Technology, Inc Recent Development
7.9 410 Medical
7.9.1 410 Medical Company Information
7.9.2 410 Medical Introduction and Business Overview
7.9.3 410 Medical Quick Injector Sales, Revenue and Gross Margin (2019-2024)
7.9.4 410 Medical Quick Injector Product Offerings
7.9.5 410 Medical Recent Development
7.10 Smisson-Cartledge Biomedical
7.10.1 Smisson-Cartledge Biomedical Company Information
7.10.2 Smisson-Cartledge Biomedical Introduction and Business Overview
7.10.3 Smisson-Cartledge Biomedical Quick Injector Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Smisson-Cartledge Biomedical Quick Injector Product Offerings
7.10.5 Smisson-Cartledge Biomedical Recent Development
8 Industry Chain Analysis
8.1 Quick Injector Industrial Chain
8.2 Quick Injector Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Quick Injector Sales Model
8.5.2 Sales Channel
8.5.3 Quick Injector Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Quick Injector was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 126
USD 3950.00
(Single User License)
The global Quick Injector market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-17
Pages: 109
USD 2900.00
(Single User License)
The global Quick Injector market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 76
USD 4250.00
(Single User License)
The global Quick Injector market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 144
USD 4900.00
(Single User License)
The global market for Quick Injector was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 99
USD 3950.00
(Single User License)
The global market for Quick Injector was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-01
Pages: 86
USD 2900.00
(Single User License)
A medical device used to quickly inject a specific dose of a drug of a certain type (usually a rescue medication). Most rapid injectors have spring retractable needles, a design that makes the injector easier to use, especially when there is no other person to assist or the injector is not medically trained. When using a self-injector, the injection site should be in accordance with the specific requirements of the relevant drug.
Published Date: 2024-02-26
Pages: 88
USD 2900.00
(Single User License)
The global market for Quick Injector was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 126
The global Quick Injector market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-17
Pages: 109
The global Quick Injector market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 76
The global Quick Injector market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 144
The global market for Quick Injector was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 99
The global market for Quick Injector was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-01
Pages: 86
A medical device used to quickly inject a specific dose of a drug of a certain type (usually a rescue medication). Most rapid injectors have spring retractable needles, a design that makes the injector easier to use, especially when there is no other person to assist or the injector is not medically trained. When using a self-injector, the injection site should be in accordance with the specific requirements of the relevant drug.
Published: 2024-02-26
Pages: 88
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now